Additional evidence from pancreatic cancer models demonstrates that KAT2A facilitates malignant progression through mechanisms involving enhanced proliferation, migratory capacity, invasive potential, epithelial-mesenchymal transition, and metabolic reprogramming [17]. The gene discussed is KAT2A; the disease is pancreatic neoplasm.